Developing and testing new drugs costs a lot of money.
new prescription drugs
In a bid to get even steeper drug discounts, Health Canada recently proposed changes to our reference-pricing system.
Nobel laureate Paul Romer’s key new insight was that human capital can produce ideas.
Insurance companies are the principal beneficiaries of Ontario’s new publicly-funded pharmacare program.
Delay or denial of access to life-saving drugs is a potential death sentence.